Skip to main content

Medicines Optimisation Framework Review (2026-2028)

We are reviewing our Medicines Optimisation Framework, originally published in April 2021. The framework document describes how AWMSG's medicines optimisation resources are created; from proposal by stakeholders, all the way through to AWMSG endorsement, dissemination, and review. This is not just a review of the documentation, but a review of all of the processes that contribute to the publication of AWMSG-endorsed medicines optimisation resources.

A vital part of this review is ensuring that we are responsive to the feedback of our stakeholders, including people who have used our resources in the past, or could use them in the future. Your feedback will help inform an extensive review of the framework and ensure that it reflects the priorities and needs of the public and health and social care professionals in Wales.

Over the course of 2026-2027, we will be carrying out a range of stakeholder engagement activities – all of which will be promoted from this webpage. Please return regularly to find out what we’re doing, and how you can contribute.

Get involved:

  • AWMSG medicines optimisation resources – General feedback survey
    Share your views on AWMSG-endorsed medicines optimisation resources, including how easy they are to navigate, the topics they cover, and how practical they are to put into practice. This survey will be open until Friday 31 July 2026.
    Access the survey here.
  • One-to-one conversations with key stakeholders
    AWTTC are carrying out a series of structured one-to-one conversations with a number of key stakeholders. If you would like to be considered for having a focused discussion on the development of AWMSG-endorsed medicines optimisation resources, how we manage our work programme and the projects we prioritise, and how we work with stakeholders throughout resource development, please get in touch with us.
Follow AWTTC: